Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Delayed Diagnosis of Disseminated Cutaneous Mycobacterium chelonae: A Diagnostic Pitfall in Immunosuppressed Patients.

International journal of dermatology·2026

Same author

Utility of the Erythema Nodosum Leprosum International Study Severity Scale for Erythema Nodosum Leprosum: A Clinically Supported Critical Appraisal.

The American journal of tropical medicine and hygiene·2025

Same author

False positive PET scan of hereditary leiomyomatosis and renal cell cancer: A case report.

Radiology case reports·2025

Same author

Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study.

Dermatology (Basel, Switzerland)·2024

Same author

Immune reconstitution inflammatory syndrome following treatment of cutaneous tuberculosis with rifampin, isoniazid, pyrazinamide, and ethambutol.

JAAD case reports·2024

Same author

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).

Dermatology and therapy·2024

Search research articles

Related Experiment Video

Updated: May 8, 2026

LED Thermo Flow — Combining Optogenetics with Flow Cytometry

LED Thermo Flow — Combining Optogenetics with Flow Cytometry

Published on: December 30, 2016

Dronaderone-induced phototoxicity.

Barry Ladizinski, David J Elpern

Journal of Drugs in Dermatology : JDD

|August 30, 2013

Summary

This summary is machine-generated.

Phototoxicity is a skin reaction to UV light exposure while taking photosensitizing drugs. A rare case of phototoxic drug eruption occurred in a patient taking dronaderone, an antiarrhythmic medication.

More Related Videos

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

Related Experiment Videos

Last Updated: May 8, 2026

LED Thermo Flow — Combining Optogenetics with Flow Cytometry

LED Thermo Flow — Combining Optogenetics with Flow Cytometry

Published on: December 30, 2016

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

Area of Science:

Dermatology
Pharmacology
Cardiology

Background:

Phototoxicity is a known adverse effect of certain medications when exposed to ultraviolet light.
Commonly implicated drugs include antibiotics, NSAIDs, diuretics, and amiodarone.
Dronedarone, a novel antiarrhythmic, shares similarities with amiodarone but has a lower incidence of adverse effects.

Observation:

A 63-year-old woman with atrial fibrillation developed a phototoxic drug eruption.
The patient was using dronedarone for maintaining normal sinus rhythm.

Findings:

Phototoxicity is rarely documented with dronedarone use.
This case highlights a potential, albeit uncommon, phototoxic reaction to dronedarone.

Implications:

Clinicians should remain vigilant for phototoxic reactions even with newer medications like dronedarone.
Further research may be needed to fully characterize the phototoxic potential of dronedarone.
Patient education regarding sun exposure is crucial when prescribing photosensitizing agents.